Dr. Jonathan Michael Mobley, MD

Dr. Mobley practices at Inova Fairfax Hospital - Unit in Falls Church, Virginia.

Dr. Mobley's NPI, 1164458782, was assigned on June 24, 2006. Dr. Mobley graduated from University of Louisville School of Medicine in 2001. Dr. Mobley holds Virginia license 0101256473.

Dr. Mobley's primary practice is Inova Fairfax Hospital - Unit, at 3300 Gallows Rd, Falls Church, VA 22046 in Falls Church City. The practice phone is (703) 698-3659.

Dr. Mobley's primary practice is Inova Fairfax Hospital - Unit in Falls Church, Virginia. Dr. Mobley is also affiliated with Inova Fairfax Hospital. The medical group on file is Inova Urgent Care Center. Dmand AI also links Dr. Mobley to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mobley practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Mobley's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Mobley's licenses on file in 2 states: Virginia and Missouri.

CMS data shows 1,450 Medicare services from Dr. Mobley across 15 procedure codes in 2024, for 572 Medicare patients. Medicare paid $116,411 for them.

CMS counts 572 Medicare patients who saw Dr. Mobley in 2024. The largest group is 75 to 84, with 257 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mobley's median patient age at 64, with 18% women.

In 2024, Dr. Mobley wrote 1,221 Medicare Part D claims for 340 patients. 94% of them were for generic drugs. CMS names the drug for 1,122 of them, across 19 drugs with 11 or more claims each, at $94,332 in total drug cost. In 2023, CMS named 865 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Mobley for performance year 2024, reported as part of a group. Dr. Mobley accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mobley as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Mobley, published from 2014 to 2018. 2014 was the busiest year, with 3. The most frequent topics are Carcinoma, Renal Cell and Kidney Neoplasms. Dr. Mobley has published most often in J Endourol. Dr. Mobley's most frequent co-authors are Robert S. Figenshau, MD, Sam B. Bhayani, MD and Goutham Vemana, MD.

CMS Open Payments shows 47 general payments to Dr. Mobley from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Astellas Pharma US Inc paid the most, $460.

Dr. Mobley graduated from University of Louisville School of Medicine in 2001.